R. Frenck

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

K. Jansen, W. Gruber, I. Scully, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report.

G. Kang, S. Bull, M. Parker, 2020, Biologicals : journal of the International Association of Biological Standardization.

EBB AND FLOW CULTIVATION OF CHRYSANTHEMUM CUTTINGS IN DIFFERENT GROWING MEDIA

K. S. Kim, F. Buwalda, R. Frenck, 1995 .

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Diane J Post, D. Montefiori, D. Szydlo, 2022, Cell Reports Medicine.

Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

E. Walsh, A. Falsey, P. Dormitzer, 2021, Nature.

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

E. Walsh, A. Falsey, P. Dormitzer, 2020, medRxiv.

Campylobacter Infection as a Trigger for Guillain-Barré Syndrome in Egypt

I. Khalil, L. Ng, T. Wierzba, 2008, PloS one.